VIVOSIM LABS INC (VIVS)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$0.28-0.29%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · VIVS
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -33.9% |
| Our one-year growth estimate | diamond | -60.0% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 26.1 percentage points more one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-09-04 · Compared with 399 industry peers · Company calendar date is not available
VIVS — legal / regulatory event — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standar…
Dated 2026-08-21
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On August 17, 2026, VivoSim Labs, Inc., a Delaware corporation (the “Company”), received a written notice (the “Notice”) from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock for the last 30 consecutive business days, the Company no longer met the requirement to maintain a mi…
Why it matters: Approval is needed to lower the exercise price of warrants. This could help liquidity and investor trust.
Supportive ifShareholders agree to change the exercise price of warrants to $0.85.
Worry ifShareholders deny the change, keeping the exercise price at $9.60.
Why it matters: How the company reacts to the delisting notice affects its public trading status.
Worry ifVivoSim meets Nasdaq's equity rules. This helps it avoid delisting.
Less concerning ifVivoSim does not meet Nasdaq's rules. This leads to delisting.
Why it matters: Larger losses might mean bigger problems. This could change how investors feel.
Worry ifNet losses reported worse than -$5 million in the upcoming earnings release.
Less concerning ifNet losses were at or better than -$5 million. This shows better financial health.
Why it matters: The company got a notice about its stockholder equity. This could impact its listing and how investors see it.
Worry ifThe company fixes the delisting notice and keeps its Nasdaq listing.
Less concerning ifThe company fails to meet Nasdaq requirements and is delisted.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$212 on $10,000 · ±2.1% | How much price usually moves either way. |
| Bad day | $1,286 loss on $10,000 · 12.9% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $9,420 loss on $10,000 · 94.2% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: If Vivosim grows, it shows that its strategy and services are in demand.
Supportive ifQuarterly revenue reports show growth more than 500% compared to last year.
Worry ifQuarterly revenue growth is less than 200% compared to last year.
Why it matters: More capital raises show the company is financially healthy. It also shows growth potential.
Supportive ifLook for news about financing or capital raises over $3 million.
Worry ifNo announcements of new financing or capital raises in the next quarter.
Why it matters: This offering could provide needed capital for growth. It may signal investor confidence.
Supportive ifThe company raises at least $10 million from the public offering.
Worry ifThe offering fails to close or raises significantly less than $10 million.
Why it matters: The success of this offering is crucial for VivoSim's working capital and growth plans.
Watch forThe company finishes the public offering. It receives the full $4 million.
Also watch forThe offering fails to close or raises less than $3 million.
Why it matters: Better operating income shows that costs are being managed. This is a step toward making money.
Supportive ifOperating income reported at less negative than -$3.19M for Q2.
Worry ifOperating income remains more negative than -$3.39M for Q2.
Why it matters: If revenue growth drops, it could signal trouble in the company's performance. This is a key indicator of health in the sector.
Worry ifRevenue growth reported below the median for the sector.
Less concerning ifRevenue growth remains above the median for the sector.
Why it matters: The company expects over 500% revenue growth. This shows strong demand for its services.
Supportive ifQuarterly revenue is over $90,000. This shows strong growth momentum.
Worry ifQuarterly revenue is below $40,000. This shows weak demand.
Why it matters: Ongoing capital raising is important for VivoSim. It helps support operations and growth plans.
Supportive ifThe company says it raised more than $3 million in capital.
Worry ifThe company does not secure more capital or faces delays in fundraising.